• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Equistone acquires Omnicare

  • Katharine Hidalgo
  • Katharine Hidalgo
  • 14 August 2019
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Equistone Partners Europe has agreed to acquire a majority stake in wholesale pharmaceutical company Omnicare Pharma.

The management team will reinvest in the transaction and will continue to lead the company. Omnicare acts as a cooperative enterprise with numerous pharmacists owning minority stakes. Around 40 pharmacists hold equity, though many may have sold their stakes in this transaction, according to Unquote sister publication Mergermarket.

The sale process saw Chequers Capital and a strategic bidder also competing for the asset, according to Mergermarket. Belgium-based pharmaceutical company Fagron and a US-based strategic bidder dropped out of the process at an early stage.

Omnicare Pharma

  • DEAL:

    Buyout

  • LOCATION:

    Unterföhring

  • SECTOR:

    Pharmaceuticals

  • FOUNDED:

    2002

  • TURNOVER:

    €670m

  • EBITDA:

    €30-35m (est)

  • STAFF:

    193

Omnicare generates revenues of €670m and is expected to achieve revenue growth of 5% in 2019.

The vendors initially priced Omnicare at more than 10x its EBITDA of €30-35m, but this may have dropped to a single-digit multiple throughout the sale process, according to Mergermarket.

The transaction is subject to regulatory approval and is expected to close in Q4 of 2019.

Company
Founded in 2002, the company distributes finished medicinal products for the manufacture of anti-cancer drugs. Since 2018, it has also offered quality assurance and educational services for specialised pharmacies and medical practices.

Headquartered in Unterföhring, Omnicare employs 193 staff. It also operates locations in Calw and Cologne.

People
Equistone Partners Europe – Dirk Schekerka (senior partner, country head DACH); Alexis Milkovic (partner); Julia Brunswicker (investment manager).
Omnicare – Oliver Tamimi (managing director).

Advisers
Equity – P + P Pöllath + Partners (legal, tax); Alvarez & Marsal (commercial due diligence); Deloitte (financial due diligence); Houlihan Lokey (debt advisory); Dechert (legal); Shearman & Sterling (legal); ETS (insurance due diligence).
Company – Hengeler Müller (legal); BCG (commercial due diligence); KPMG (financial due diligence); EY (tax); Lincoln International (M&A); Honert & Partner (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • DACH
  • Healthcare
  • Germany
  • healthcare
  • Equistone Partners Europe
  • Alvarez & Marsal
  • Houlihan Lokey
  • Deloitte
  • Dechert
  • KPMG
  • EY (Ernst & Young)
  • Lincoln International

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013